Acousia Therapeutics
- Frank Kalkbrenner
As Managing Director of Acousia’s lead investor, Boehringer Ingelheim (BI) Venture Fund, Frank brings extensive experience in drug discovery and development as well as licensing and business development.
Acousia Therapeutics
As Managing Director of Acousia’s lead investor, Boehringer Ingelheim (BI) Venture Fund, Frank brings extensive experience in drug discovery and development as well as licensing and business development.